Medicament delivery device with adhesive assembly

Abstract

A drug delivery device is provided that includes an adhesive assembly configured to secure the drug delivery device to a patient to permit subcutaneous delivery of a drug from a container to the patient and to permit removal of the drug delivery device from the patient after completion of delivery of the drug.SOLUTION: The medicament delivery device includes a housing, a container, a drive assembly configured to move a stopper within the container, a needle, and a needle shield secured to the housing and receiving a portion of the needle, wherein the adhesive assembly includes an adhesive layer secured to a bottom surface of the housing and a liner secured to the adhesive layer. The liner is configured to be removed from the adhesive layer and comprises a protrusion, and the needle shield comprises a liner opening. The protrusion is received by the liner opening to secure the liner to the needle shield, and the liner is configured to be separated from the adhesive layer upon removal of the needle shield from the housing.SELECTED DRAWING: Figure 19

Description

[Technical Field]

[0001] This application claims priority to U.S. Provisional Application Serial No. 63 / 116,030, entitled "Drug Delivery Device with Adhesive Assembly," filed November 19, 2020, the entire disclosure of which is incorporated herein by reference. [Background technology]

[0002] FIELD OF THE DISCLOSURE The present disclosure relates generally to drug delivery devices, and more particularly to drug delivery devices having adhesive liners.

[0003] <Description of Related Art> Various types of automatic injection and drug delivery devices have been developed to allow untrained individuals to administer or self-inject medications and other liquid therapeutic formulations. These devices typically include a reservoir prefilled with the liquid therapeutic formulation and some type of automatic needle mechanism that can be triggered by the user. Automatic injectors are commonly used when the volume of fluid or medication to be administered is a fixed volume, typically 1 mL, or less, and the injection time for these automatic injectors is typically approximately 10–15 seconds. When the volume of fluid or medication to be administered exceeds 1 mL, the injection time generally becomes longer, making it difficult for the patient to maintain contact between the device and the target area on the patient's skin. Furthermore, the larger the volume of medication to be administered, the more desirable the injection time. The traditional method for slowly injecting medication into a patient is to start an intravenous infusion and slowly infuse the medication into the patient's body. Such procedures are typically performed in hospitals or outpatient settings.

[0004] Certain devices allow for self-injection at home, slowly infusing a liquid therapeutic formulation into a patient's skin. In some cases, these devices are small enough (both in height and overall size) to be "worn" by the patient while the liquid therapeutic formulation is being injected into the patient. These devices typically include a pump or other type of delivery mechanism that forces the liquid therapeutic formulation from a reservoir into the injection needle. Such devices also typically include a valve or flow control mechanism to initiate the flow of the liquid therapeutic formulation at the appropriate time, and a trigger mechanism to initiate the injection. Summary of the Invention [Problem to be solved by the invention]

[0005] Provided is a drug delivery device including an adhesive assembly configured to secure the drug delivery device to a patient to enable delivery of a drug from a container to the patient's subcutaneous tissue and to enable removal of the drug delivery device from the patient after delivery of the drug is completed. [Means for solving the problem]

[0006] In one aspect, a medication delivery device includes a housing having a top surface and a bottom surface; a container received within the housing, the container including a stopper configured to move within the container and configured to receive a medication; a drive assembly configured to move the stopper; a needle having a retracted position in which the needle is disposed within the housing and an extended position in which a portion of the needle protrudes from the housing; a needle shield secured to the housing and receiving a portion of the needle; and an adhesive assembly including an adhesive layer secured to the bottom surface of the housing and a liner secured to the adhesive layer. The liner is configured to be detached from the adhesive layer. The liner includes one of a protrusion and a liner opening, and the needle shield includes the other of the protrusion and the liner opening. The protrusion is received by the liner opening and secures the liner to the needle shield. The liner is configured to be separated from the adhesive layer when the needle shield is removed from the housing.

[0007] The liner may include a protrusion, and the needle shield may include a liner opening. The liner and adhesive layer may define a clearance opening that receives a portion of the protrusion.

[0008] The liner may include a body covering at least a portion of the adhesive layer and an extension extending from the body, the extension including one of the protrusion and the liner opening. The needle shield may be disposed between the liner body and the liner extension. The liner body may completely cover the adhesive layer. The protrusion and the liner opening may form a snap fit.

[0009] In a further aspect, an adhesive assembly for a medication delivery device includes a housing, a needle having a retracted position in which the needle is disposed within the housing and an extended position in which a portion of the needle protrudes from the housing, and a needle shield secured to the housing and receiving a portion of the needle. The adhesive assembly for the medication delivery device includes an adhesive layer configured to be secured to a bottom surface of the housing, and a liner secured to the adhesive layer and configured to be detached from the adhesive layer. The liner includes a protrusion configured to be received by a liner opening defined by the needle shield, and the liner is configured to be separated from the adhesive layer upon removal of the needle shield from the housing.

[0010] The liner and adhesive pad may define a clearance opening to receive a portion of the protrusion. The liner includes a main body covering at least a portion of the adhesive layer and an extension extending from the main body, with the protrusion disposed on the extension of the liner. The liner may include a fold line separating the main body of the liner from the extension of the liner, with the extension of the liner configured to be folded relative to the main body of the liner about the fold line. The main body of the liner may completely cover the adhesive layer. The protrusion of the liner is configured to be snap-fit ​​onto the needle shield. [Brief explanation of the drawings]

[0011] The above and other features and advantages of the present disclosure, and the manner in which they are achieved, will become more apparent, and the disclosure itself will be better understood, by reference to the following description of embodiments of the disclosure taken in conjunction with the accompanying drawings, in which:

[0012] [Figure 1] 1 is a perspective view of a drug delivery system according to one embodiment of the present invention. [Figure 2] 2 is a perspective cross-sectional view of the drug delivery system of FIG. 1 according to one embodiment of the present invention. [Figure 3] 2 is a front cross-sectional view of the drug delivery system of FIG. 1 according to one embodiment of the present invention. [Figure 4] 2 is a top view of the drug delivery system of FIG. 1 with the top of the housing removed and the drug delivery system in a pre-use position according to one embodiment of the present invention. [Figure 5] 2 is a top cross-sectional view of the drug delivery system of FIG. 1, showing the drug delivery system in a pre-use position, according to one embodiment of the present invention. [Figure 6] 2 is a front cross-sectional view of the drug delivery system of FIG. 1, showing the drug delivery system in a pre-use position, according to one embodiment of the present invention. [Figure 7] 2 is a top view of the drug delivery system of FIG. 1 with the top of the housing removed and the drug delivery system in an initial operating position according to one embodiment of the present invention. [Figure 8] 2 is a top cross-sectional view of the drug delivery system of FIG. 1, showing the drug delivery system in an initial actuated position, according to one embodiment of the present invention. [Figure 9] 2 is a front cross-sectional view of the drug delivery system of FIG. 1, showing the drug delivery system in an initial actuated position, according to one embodiment of the present invention. [Figure 10] 2 is a top view of the drug delivery system of FIG. 1 with the top of the housing removed and the drug delivery system in a use position according to one embodiment of the present invention. [Figure 11] 2 is a top cross-sectional view of the drug delivery system of FIG. 1, showing the drug delivery system in a position of use, according to one embodiment of the present invention. [Figure 12]2 is a front cross-sectional view of the drug delivery system of FIG. 1, showing the drug delivery system in a position of use, according to one embodiment of the present invention. [Figure 13] 2 is a top view of the drug delivery system of FIG. 1 with the top of the housing removed and the drug delivery system in a post-use position according to one embodiment of the present invention. [Figure 14] 2 is a top cross-sectional view of the drug delivery system of FIG. 1, showing the drug delivery system in a post-use position, according to one embodiment of the present invention. [Figure 15] 2 is a front cross-sectional view of the drug delivery system of FIG. 1, showing the drug delivery system in a post-use position, according to one embodiment of the present invention. [Figure 16] FIG. 1 is a top view of an adhesive assembly and a needle shield according to one aspect of the present invention. [Figure 17] FIG. 17 is a partial cross-sectional view taken along line 17-17 of FIG. 16. [Figure 18] FIG. 18 is a cross-sectional view taken along line 18-18 of FIG. 16. [Figure 19] FIG. 17 is a partial cross-sectional view of the adhesive assembly and needle shield of FIG. 16, showing the liner of the adhesive assembly secured to the needle shield. [Figure 20] 17 is a cross-sectional view of the adhesive assembly and needle shield of FIG. 16, showing the adhesive assembly and needle shield secured to the medication delivery device of FIG. 1. DETAILED DESCRIPTION OF THE INVENTION

[0013] The following description is provided to enable any person skilled in the art to make and use the described embodiments contemplated for practicing the invention. However, various modifications, equivalents, variations, and alternatives will remain readily apparent to those skilled in the art. All such modifications, variations, equivalents, and alternatives are intended to be within the spirit and scope of the present invention.

[0014] In the following description, the terms "upper," "lower," "right," "left," "portrait," "horizontal," "upper," "lower," "horizontal," "vertical," and derivatives thereof, refer to the present invention as oriented in the drawing figures. However, it should be understood that the present invention may contemplate various alternative modifications unless expressly specified to the contrary. It should also be understood that the specific devices illustrated in the accompanying drawings and described in the following specification are merely exemplary embodiments of the present invention. Accordingly, specific dimensions and other physical characteristics related to the embodiments disclosed herein are not to be considered limiting.

[0015] 1-15 , a medication delivery device 10 according to one embodiment of the present disclosure includes a drive assembly 12, a reservoir 14, a valve assembly 16, and a needle actuator assembly 18. The drive assembly 12, the reservoir 14, the valve assembly 16, and the needle actuator assembly 18 are at least partially disposed within a cavity defined by a housing 20. The housing 20 includes a top 22 and a bottom 24, although other suitable configurations of the housing 20 may be utilized. In one embodiment, the medication delivery device 10 is a syringe device configured to be worn or secured to a user and to deliver a predetermined dose of medication provided in the reservoir 14 to the user via injection. The device 10 may be utilized to perform a “bolus injection,” which delivers medication over a period of time. The medication may be delivered over a period of up to 45 minutes, although other suitable injection volumes and durations may be utilized. The bolus administration or delivery may be rate-controlled or may not require specific rate control. The device 10 may deliver medication to the user at a fixed pressure with a variable rate. The general operation of device 10 is described below with reference to FIGS. 1-15.

[0016] 1-15 , device 10 is configured to be actuated by a user engaging activation button 26, resulting in needle 28 of needle assembly 18 penetrating the user's skin, actuation of drive assembly 12 placing needle 28 in fluid communication with container 14 to expel fluid or medicament from container 14, and withdrawal of needle 28 after medicament injection is complete. The general operation of the medicament delivery system is shown and described in WO 2013 / 155153 and WO 2014 / 179774, which are incorporated herein by reference in their entireties. Housing 20 of device 10 includes indicator window 30 for viewing indicator arrangement 32 configured to provide a user with an indication regarding the status of device 10, and container window 31 for viewing container 14. Indicator window 30 may be a magnifying lens to provide a clear view of indicator arrangement 32. Indicator arrangement 32 moves with needle actuator assembly 18 during use of device 10 to indicate the pre-use, use, and post-use states of device 10. Indicator arrangement 32 provides a visual indication as to the state, although other suitable indications, such as audible or tactile, may be provided as alternative or additional indications.

[0017] 4-6, during the pre-use position of device 10, container 14 is spaced from drive assembly 12 and valve assembly 16, and needle 28 is in the retracted position. As shown in FIGS. 7-9, during initial actuation of device 10, drive assembly 12 engages container 14 and moves container 14 toward valve assembly 16, which is configured to penetrate closure 36 of container 14 and place the medicament within container 14 in fluid communication with needle 28 via tubing (not shown) or other suitable arrangement. Drive assembly 12 is configured to engage stopper 34 of container 14, and due to the incompressibility of the fluid or medicament within container 14, initially moves the entire container 14 into engagement with valve assembly 16. More specifically, drive assembly 12 is configured to engage spacer 40 received by stopper 34. Initial actuation of device 10 is triggered by engagement of actuator button 26 by a user, which releases needle actuator assembly 18 and drive assembly 12, as described in more detail below. During initial actuation, needle 28 is still in the retracted position and is about to move to the extended position to inject the user of device 10 .

[0018] As shown in FIGS. 10-12 , during the use position of device 10, needle 28 is in an extended position at least partially outside housing 20 so that drive assembly 12 can move stopper 34 within container 14 to deliver medication from container 14 through needle 28 to the user. In the use position, valve assembly 16 has already penetrated closure 36 of container 14 to place container 14 in fluid communication with needle 28, allowing drive assembly 12 to move stopper 34 relative to container 14 so that fluid can be expelled from container 14. In the post-use position of device 10, shown in FIGS. 13-15 , needle 28 is in a retracted position, engaging pad 38 to seal needle 28 and prevent residual flow of fluid or medication from container 14. Reservoir 14 and valve assembly 16 may be those shown and described in International Publication No. WO 2015 / 081337, the entire contents of which are incorporated herein by reference.

[0019] 16-20 , the medication delivery device 10 of FIGS. 1-15 may include a needle shield 42 secured to the housing 20 and receiving a portion of the needle 28. The housing 20 includes a top surface 44 and a bottom surface 46. The needle shield 42 includes a cylindrical portion 48 received within the housing 20 and surrounding at least a portion of the needle 28. The needle shield 42 may be secured to the housing 20 by gripping or engaging a portion of the housing 20, or may be secured to the housing 20 via a friction fit with an opening in the housing 20. The needle shield 42 may be configured to maintain sterility of the needle 28 in a pre-use position and to prevent accidental actuation of the medication delivery device 10. The medication delivery device 10 may also include an adhesive assembly 50 configured to secure the medication delivery device 10 to a patient to enable subcutaneous delivery of a medication from the container 14 and to enable removal of the device 10 from the patient after delivery of the medication is complete. The adhesive assembly 50 includes an adhesive layer 52 secured to the bottom surface 46 of the housing 20 and a liner 54 secured to the adhesive layer 52. The liner 54 is configured to be removed from the adhesive layer 52, exposing the adhesive layer 52 and allowing the adhesive layer 52 to be applied to a surface, such as a patient's skin surface. The liner 54 includes a protrusion 60, and the needle shield 42 defines a liner opening 62; however, the liner 54 may include a liner opening 62, and the needle shield 42 may include a protrusion 60. The liner 54 is shown with two protrusions 60, and the needle shield 42 includes two liner openings 62; however, one or more protrusions 60 and liner openings 62 may be utilized. As shown in FIG. 19 , the protrusions 60 are received in the liner openings 62, securing the liner 54 to the needle shield 42. The liner 54 is configured to be separated from the adhesive layer 52 upon removal of the needle shield 42 from the housing 20.

[0020] 16, 17, and 19, liner 54 and adhesive layer 52 define a clearance opening 64 that receives a portion of protrusion 60. Clearance opening 64 provides space for protrusion 60 when protrusion 60 is secured to needle shield 42.

[0021] 16-20 , the liner 54 includes a main body 70 that covers at least a portion of the adhesive layer 52 and an extension 72 extending from the main body 70. The extension 72 of the liner 54 includes a protrusion 60. When the liner 54 is secured to the needle shield 42 via the protrusion 60, the needle shield 42 is positioned between the main body 70 of the liner 54 and the extension 72 of the liner 54. However, the adhesive assembly 50 may be configured such that when the needle shield 42 is secured to the liner 54, the extension 72 is positioned between the main body 70 and the needle shield 42, with the protrusion(s) 60 extending from the extension 72 toward the needle shield 42. Although the main body 70 of the liner 54 completely covers the adhesive layer 52, other suitable configurations in which the main body 70 of the liner 54 covers only a portion of the adhesive layer 52 may also be utilized. The protrusion 60 and the liner opening 62 form a snap fit to secure the liner 54 to the needle shield 42. The liner 54 includes a fold line 74 separating a main body 70 of the liner 54 from an extension portion 72 of the liner 54 , and the extension portion 72 of the liner 54 is configured to fold relative to the main body 70 of the liner 54 about the fold line 74 .

[0022] When the needle shield 42 is removed from the medication delivery device 10 by grasping the needle shield 42 and moving it away from the bottom surface 46 of the housing 20, the extension 72 of the liner 54 moves with the needle shield 42, with the extension 72 connected to the needle shield 42 via the protrusion 60 and the liner opening 62. As the movement of the needle shield 42 and the extension 72 of the liner 54 continues, the extension 72 of the liner 54 peels the main body 70 of the liner 54 from the adhesive layer 52. The extension 72 of the liner 54 is attached to the outer periphery of the main body 70 of the liner 54 and helps to facilitate peeling of the liner 54 from the adhesive layer 52, although other suitable arrangements may be utilized.

[0023] Elements of one disclosed aspect can be combined with elements of one or more other disclosed aspects to form different combinations, all of which are contemplated within the scope of the invention.

[0024] While this disclosure has been described as having an exemplary design, the disclosure can be further modified within the spirit and scope of the disclosure. Accordingly, this application is intended to cover any variations, uses, or adaptations of the disclosure using its general principles. Further, this application is intended to cover such departures from the disclosure as come within known or customary practice in the art to which this disclosure pertains and fall within the limits of the appended claims.

Claims

1. a housing having a top surface and a bottom surface; a container received within the housing and configured to receive a medicament, the container including a stopper configured to move within the container; a drive assembly configured to move the stopper; a needle having a retracted position disposed within the housing and an extended position in which a portion of the needle protrudes from the housing; a needle shield secured to the housing and configured to receive a portion of the needle; an adhesive assembly including an adhesive layer secured to a bottom surface of the housing and a liner secured to the adhesive layer, the liner configured to be removed from the adhesive layer, the liner including a protrusion, the needle shield including a liner opening, the protrusion being received by the liner opening and securing the liner to the needle shield, the liner configured to be separated from the adhesive layer upon removal of the needle shield from the housing; 10. A drug delivery device comprising:

2. The medication delivery device of claim 1 , wherein the liner and the adhesive layer define a clearance opening that receives a portion of the protrusion.

3. 2. The medication delivery device of claim 1, wherein the liner comprises a main body covering at least a portion of the adhesive layer and an extension extending from the main body, the extension of the liner comprising one of the protrusion and the liner opening.

4. The medication delivery device of claim 3 , wherein the needle shield is disposed between the liner body and the liner extension.

5. The medication delivery device of claim 3 , wherein the body of the liner completely covers the adhesive layer.

6. The medication delivery device of claim 1 , wherein the protrusion and the liner opening form a snap fit.

Images